|
1
|
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
|
Circulation
|
2010
|
6.71
|
|
2
|
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
|
Eur Heart J
|
2010
|
4.13
|
|
3
|
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1.
|
Cardiovasc Res
|
2005
|
3.99
|
|
4
|
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.
|
Am J Hum Genet
|
2002
|
2.95
|
|
5
|
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
|
Circulation
|
2006
|
2.81
|
|
6
|
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia.
|
J Am Coll Cardiol
|
2008
|
2.06
|
|
7
|
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria.
|
Eur Heart J
|
2008
|
2.05
|
|
8
|
Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
|
Circ Cardiovasc Genet
|
2013
|
1.81
|
|
9
|
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
|
J Am Coll Cardiol
|
2010
|
1.62
|
|
10
|
Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates.
|
Hum Pathol
|
2005
|
1.57
|
|
11
|
Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies.
|
Eur Heart J
|
2006
|
1.56
|
|
12
|
Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy.
|
Am J Cardiol
|
2009
|
1.50
|
|
13
|
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification.
|
J Cardiovasc Electrophysiol
|
2013
|
1.49
|
|
14
|
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
|
Circulation
|
2005
|
1.47
|
|
15
|
Pathophysiology of arrhythmogenic cardiomyopathy.
|
Nat Rev Cardiol
|
2011
|
1.25
|
|
16
|
Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy.
|
Eur Heart J
|
2012
|
1.20
|
|
17
|
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy.
|
J Exp Med
|
2009
|
1.18
|
|
18
|
Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance.
|
Circ Arrhythm Electrophysiol
|
2011
|
1.14
|
|
19
|
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro.
|
BMC Med Genet
|
2007
|
1.11
|
|
20
|
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.93
|
|
21
|
Arrhythmogenic right ventricular cardiomyopathy.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.91
|
|
22
|
The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy.
|
Eur J Hum Genet
|
2010
|
0.89
|
|
23
|
Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias.
|
Clin Chem
|
2004
|
0.88
|
|
24
|
TAIL1: an isthmin-like gene, containing type 1 thrombospondin-repeat and AMOP domain, mapped to ARVD1 critical region.
|
Gene
|
2004
|
0.87
|
|
25
|
Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening.
|
Circulation
|
2011
|
0.87
|
|
26
|
Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.
|
Europace
|
2007
|
0.87
|
|
27
|
Autonomic profile and arrhythmic risk stratification after surgical repair of tetralogy of Fallot.
|
Am Heart J
|
2004
|
0.85
|
|
28
|
Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes.
|
Eur J Hum Genet
|
2003
|
0.85
|
|
29
|
Desmin mutations and arrhythmogenic right ventricular cardiomyopathy.
|
Am J Cardiol
|
2012
|
0.84
|
|
30
|
Heart rate variability in arrhythmogenic right ventricular cardiomyopathy correlation with clinical and prognostic features.
|
Pacing Clin Electrophysiol
|
2002
|
0.83
|
|
31
|
Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy.
|
Am J Cardiol
|
2013
|
0.82
|
|
32
|
Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy.
|
Eur J Hum Genet
|
2013
|
0.81
|
|
33
|
Late-onset arrhythmogenic right ventricular cardiomyopathy.
|
J Cardiovasc Med (Hagerstown)
|
2006
|
0.80
|
|
34
|
Gender differences and role of pregnancy in the history of post-surgical women affected by tetralogy of Fallot.
|
PLoS One
|
2012
|
0.79
|
|
35
|
Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings.
|
Europace
|
2006
|
0.77
|
|
36
|
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations.
|
Am J Cardiol
|
2012
|
0.77
|
|
37
|
Noninvasive cardiac screening in young athletes with ventricular arrhythmias.
|
Am J Cardiol
|
2012
|
0.77
|
|
38
|
Pharmacotherapy and other therapeutic modalities for managing Arrhythmogenic Right Ventricular Cardiomyopathy.
|
Cardiovasc Drugs Ther
|
2015
|
0.76
|
|
39
|
Echocardiographic findings in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
40
|
Letter regarding article by Nasir et al, "Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria".
|
Circulation
|
2005
|
0.75
|
|
41
|
Arrhythmogenic right ventricular cardiomyopathy is a life-threatening disease at high risk for cardiac arrest during effort. Minor forms are as dangerous as major forms?
|
J Cardiovasc Med (Hagerstown)
|
2006
|
0.75
|
|
42
|
[Diagnosis and therapy of arrhythmogenic right ventricular cardiomyopathy].
|
G Ital Cardiol (Rome)
|
2014
|
0.75
|
|
43
|
Management of arrhythmogenic right ventricular cardiomyopathy.
|
Minerva Med
|
2016
|
0.75
|
|
44
|
Clinical management of a pregnant woman with Filamin C cardiomyopathy.
|
J Cardiovasc Med (Hagerstown)
|
2022
|
0.75
|